Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2025-12-25 @ 7:36 PM
Study NCT ID:
NCT04481932
Status:
RECRUITING
Last Update Posted:
2020-07-22
First Post:
2020-07-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer
Sponsor:
Peking University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-13
First Submit QC Date:
None
Study First Post Date:
2020-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-19
Last Update Post Date:
2020-07-22
Last Update Post Date Type:
ACTUAL